3billion Launches Genomic Newborn Screening Service for 595 Genetic Conditions
The new 3B-NEO service uses whole exome and whole genome sequencing to identify risks for serious childhood-onset disorders before symptoms appear.
The new 3B-NEO service uses whole exome and whole genome sequencing to identify risks for serious childhood-onset disorders before symptoms appear.
Researchers developed a test for early detection of T. cruzi infection in newborns, showing promise for better management of Chagas disease.
Late diagnosis in the era of universal newborn screening negatively affects growth and health outcomes in infants with cystic fibrosis.
The Oklahoma State Public Health Laboratory transferred to a new facility in the midst of the COVID-19 crisis.
Read MoreGenomenon announced a partnership with Rady Children’s Institute for Genomic Medicine to improve diagnosis & treatment decisions for newborns.
Read MoreA wireless, bioelectronic pacifier could eliminate the need for invasive, twice-daily blood draws to monitor babies’ electrolytes in newborn intensive care units (NICUs)
Read MoreDried blood spot testing provides clinical labs an easy-to-collect, reliable, and cost-effective means to test for a variety of diseases.
Read MoreThe alliance aims to make Spinal Muscular Atrophy testing mandatory in European newborn screening programs by 2025.
Read MoreThe combined type 1 diabetes risk score approach incorporates genetics, clinical factors such as family history, and the count of islet autoantibodies.
Read MoreOZ Systems has launched the first newborn screening suite designed specifically for hospitals, aiming to improve newborn patient safety and standard care.
Read MoreThe in vitro diagnostic kit is intended for the semiquantitative measurement and evaluation of acylcarnitine, amino acid, free carnitine lysophospholipid, nucleoside, and succinylacetone concentrations.
Read More